RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
Add like
Add dislike
Add to saved papers

Cytopathogenicity of Naegleria fowleri in mammalian cell cultures.

A total of 13 strains of Naegleria fowleri were cytopathogenic for lung, kidney, foreskin, ovary, connective tissue, neuroblastoma, laryngeal carcinoma, and cervical carcinoma mammalian cell lines. The strains of N. fowleri varied considerably in their ability to produce a cytopathic effect (CPE). Likewise, the different mammalian cell lines exhibited varying degrees of susceptability to the cytopathogenicity of the amebae. The African green-monkey kidney (Vero) cell line proved to be useful for assessing the cytopathogenic potential of N. fowleri strains. Although one strain failed to produce CPE in Vero-cell cultures, it did so in the two neuroblastoma cell lines. Other factors affecting the extent of CPE produced were incubation temperature, ameba: mammalian cell ratio, and the length of time during which amebae were maintained in cell culture.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app